Orchid Pharma

{
  "main_header": {
    "sid": 653435,
    "name": "Orchid Pharma",
    "stock_name": "Orchid Pharma",
    "full_name": "Orchid Pharma Ltd",
    "name_url": "stocks-analysis/orchid-pharma",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "708.65",
    "chg": -11.4,
    "chgp": "-1.58%",
    "dir": -1,
    "prev_price": "720.05",
    "mcapval": "3,573.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 524372,
    "symbol": "ORCHPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE191A01027",
    "curr_date": "May 12",
    "curr_time": "",
    "bse_nse_vol": "1.16 lacs",
    "exc_status": "Active",
    "traded_date": "May 12, 2026",
    "traded_date_str": "2026 05 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/orchid-pharma-653435-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Orchid Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/orchid-pharma-ltd-is-rated-strong-sell-3987386",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/OrchidPharmaLtd_mojoScore_3987386.png",
        "date": "2026-05-12 10:10:25",
        "description": "Orchid Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Orchid Pharma Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Comparisons",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-valuation-shifts-signal-heightened-price-risk-amid-sector-comparisons-3978697",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/OrchidPharmaLtd_valuationdot_3978697.png",
        "date": "2026-05-07 08:01:22",
        "description": "Orchid Pharma Ltd has witnessed a significant shift in its valuation parameters, moving from an expensive to a very expensive rating, driven primarily by a sharp rise in its price-to-earnings (P/E) ratio to 129.78. Despite this valuation surge, the company’s recent returns have been mixed, with strong short-term gains contrasting with underperformance over longer horizons relative to the Sensex."
      },
      {
        "title": "Orchid Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/orchid-pharma-ltd-is-rated-strong-sell-3972139",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/OrchidPharmaLtd_mojoScore_3972139.png",
        "date": "2026-05-01 10:10:17",
        "description": "Orchid Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Orchid Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3965574",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/OrchidPharmaLtd_technicaldot_3965574.png",
        "date": "2026-04-28 08:03:21",
        "description": "Orchid Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in price momentum and technical indicators, reflecting a complex market sentiment. Despite a recent day gain of 3.39%, the stock remains under pressure with a strong sell rating and mixed signals from key technical tools such as MACD, RSI, and moving averages."
      },
      {
        "title": "Orchid Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/orchid-pharma-ltd-is-rated-strong-sell-3953858",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/OrchidPharmaLtd_mojoScore_3953858.png",
        "date": "2026-04-20 10:10:26",
        "description": "Orchid Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 February 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below are based on the company’s current position as of 20 April 2026, providing investors with the latest insights into its performance and valuation."
      },
      {
        "title": "Orchid Pharma Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/orchid-pharma-ltd-is-rated-strong-sell-3939445",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/OrchidPharmaLtd_mojoScore_3939445.png",
        "date": "2026-04-09 10:10:18",
        "description": "Orchid Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Feb 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 09 April 2026, providing investors with the latest insights into its performance and valuation."
      },
      {
        "title": "Orchid Pharma Ltd Opens 8.42% Higher in Sharp Gap Up, But Can the Technicals Support It?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-opens-strong-with-significant-gap-up-on-842-gain-3937188",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/OrchidPharmaLtd_gapup_3937188.png",
        "date": "2026-04-08 09:50:21",
        "description": ""
      },
      {
        "title": "Orchid Pharma Gains 3.70%: Key Market Moves and Technical Signals This Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-gains-370-key-market-moves-and-technical-signals-this-week-3932165",
        "imagepath": "",
        "date": "2026-04-04 16:05:19",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>30 Mar:</strong> New 52-week low at Rs.478.35 amid market weakness</p>\n                    <p><strong>1 Apr:</strong> Intraday high surge of 7.21%, closing at Rs.517.00</p>\n                    <p><strong>2 Apr:</strong> Moderate gain of 0.99%, closing at Rs.522.10</p>\n                    <p><strong>3 Apr:</strong> No trading data available</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.503.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.522.10</div><div class=\"stat-change posit..."
      },
      {
        "title": "Orchid Pharma Ltd Surges 7.21% to Day's High of Rs 499 — Outperforms Sector by 1.52 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/orchid-pharma-ltd-hits-intraday-high-with-721-surge-on-1-april-2026-3927811",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/OrchidPharmaLtd_priceRelatedfactors_3927811.png",
        "date": "2026-04-01 09:32:08",
        "description": "The Sensex gained 2.7% on 1 Apr 2026, yet Orchid Pharma Ltd outpaced the broader market with a 7.21% intraday rally, reaching a high of Rs 499. This 1.52 percentage-point outperformance over its Pharmaceuticals &amp; Biotechnology sector peers highlights a distinctly stock-specific surge rather than a market-wide lift."
      }
    ],
    "total": 322,
    "sid": "653435",
    "stock_news_url": "https://www.marketsmojo.com/news/orchid-pharma-653435"
  },
  "announcements": [
    {
      "details": "Orchid Pharma Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from December 23, 2019 to December 30, 2019 ( both days inclusive) for the purpose of Annual General Meeting to be held on December 30, 2019.",
      "source": "NSE",
      "caption": "Orchid Pharma Limited - AGM/Book Closure",
      "datetime": "05-Dec-2019"
    },
    {
      "details": "Orchid Pharma Limited has informed the Exchange regarding Board meeting held on November 14, 2019.",
      "source": "NSE",
      "caption": "Orchid Pharma Limited - Outcome of Board Meeting",
      "datetime": "15-Nov-2019"
    },
    {
      "details": " <table><tr><td>Orchid Pharma Limited has informed the Exchange regarding Board meeting held on August 12, 2019. </td></tr></table>",
      "source": "NSE",
      "caption": "Outcome of Board Meeting",
      "datetime": "12-Aug-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Orchid Pharma Ltd has declared <strong>30%</strong> dividend, ex-date: 13 Sep 12",
          "dt": "2012-09-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Orchid Pharma Ltd is Rated Strong Sell

2026-05-12 10:10:25

Orchid Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Orchid Pharma Ltd Valuation Shifts Signal Heightened Price Risk Amid Sector Comparisons

2026-05-07 08:01:22

Orchid Pharma Ltd has witnessed a significant shift in its valuation parameters, moving from an expensive to a very expensive rating, driven primarily by a sharp rise in its price-to-earnings (P/E) ratio to 129.78. Despite this valuation surge, the company’s recent returns have been mixed, with strong short-term gains contrasting with underperformance over longer horizons relative to the Sensex.

Read full news article

Orchid Pharma Ltd is Rated Strong Sell

2026-05-01 10:10:17

Orchid Pharma Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 01 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Orchid Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-04-28 08:03:21

Orchid Pharma Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in price momentum and technical indicators, reflecting a complex market sentiment. Despite a recent day gain of 3.39%, the stock remains under pressure with a strong sell rating and mixed signals from key technical tools such as MACD, RSI, and moving averages.

Read full news article

Orchid Pharma Ltd is Rated Strong Sell

2026-04-20 10:10:26

Orchid Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 February 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below are based on the company’s current position as of 20 April 2026, providing investors with the latest insights into its performance and valuation.

Read full news article

Orchid Pharma Ltd is Rated Strong Sell

2026-04-09 10:10:18

Orchid Pharma Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 13 Feb 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 09 April 2026, providing investors with the latest insights into its performance and valuation.

Read full news article

Orchid Pharma Ltd Opens 8.42% Higher in Sharp Gap Up, But Can the Technicals Support It?

2026-04-08 09:50:21

Read full news article

Orchid Pharma Gains 3.70%: Key Market Moves and Technical Signals This Week

2026-04-04 16:05:19

Key Events This Week

30 Mar: New 52-week low at Rs.478.35 amid market weakness

1 Apr: Intraday high surge of 7.21%, closing at Rs.517.00

2 Apr: Moderate gain of 0.99%, closing at Rs.522.10

3 Apr: No trading data available

Week Open

Rs.503.45

Week Close

Rs.522.10

Read full news article

Orchid Pharma Ltd Surges 7.21% to Day's High of Rs 499 — Outperforms Sector by 1.52 Percentage Points

2026-04-01 09:32:08

The Sensex gained 2.7% on 1 Apr 2026, yet Orchid Pharma Ltd outpaced the broader market with a 7.21% intraday rally, reaching a high of Rs 499. This 1.52 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific surge rather than a market-wide lift.

Read full news article

View All News